venBio Global Strategic GP II, Ltd.

10% owner at Akero Therapeutics, Inc. · on record since Jun 25, 2019
10% owner at Checkmate Pharmaceuticals, Inc. · on record since Aug 12, 2020
10% owner at IMPERIAL INDUSTRIES INC · on record since Apr 29, 2021

Insider trading activity of venBio Global Strategic GP II, Ltd.

Transactions on record: 16; since Jun 25, 2019

Open-market buys: 2; $7M

Open-market sells: 6; $8.5M

Companies traded: 2; last filing May 4, 2022

Figures computed from official regulatory filings — .

Companies where venBio Global Strategic GP II, Ltd. has traded

Checkmate Pharmaceuticals, Inc.11 tx · $11.5M · May 4, 2022
Akero Therapeutics, Inc.5 tx · $4M · Jun 25, 2019

Track record of venBio Global Strategic GP II, Ltd.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of venBio Global Strategic GP II, Ltd.

Co-insiders of venBio Global Strategic GP II, Ltd.

Adelman Robert JAkero Therapeutics, Inc. +2
GOODMAN COREY SAkero Therapeutics, Inc. +2
venBio Global Strategic GP II, L.P.Akero Therapeutics, Inc. +2
venBio Global Strategic Fund II L.P.Akero Therapeutics, Inc. +1
5AM Opportunities I (GP), LLCIMPERIAL INDUSTRIES INC
5AM Opportunities I, L.P.IMPERIAL INDUSTRIES INC
5AM Partners V, LLCIMPERIAL INDUSTRIES INC
5AM Ventures V, L.P.IMPERIAL INDUSTRIES INC
Amin RajivIMPERIAL INDUSTRIES INC
Apple Tree Partners IV, L.P.Akero Therapeutics, Inc.
Atlas Venture Associates Opportunity I, LLCAkero Therapeutics, Inc.
Atlas Venture Associates Opportunity I, L.P.Akero Therapeutics, Inc.
Atlas Venture Associates XI, LLCAkero Therapeutics, Inc.
Atlas Venture Associates XI, L.P.Akero Therapeutics, Inc.
Atlas Venture Fund XI, L.P.Akero Therapeutics, Inc.
Atlas Venture Opportunity Fund I, L.P.Akero Therapeutics, Inc.
ATP III GP, Ltd.Akero Therapeutics, Inc.
BAM Partners TrustIMPERIAL INDUSTRIES INC
BASH ALANCheckmate Pharmaceuticals, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Checkmate Pharmaceuticals, Inc.Listing unverified	May 4, 2022	Sell	-153,700	10.38 USD	$1.6M		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 4, 2022	Sell	-37,500	10.37 USD	$388.9K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 4, 2022	Sell	-79,475	10.37 USD	$824.2K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 21, 2022	Sell	-62,200	10.38 USD	$645.6K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 21, 2022	Sell	-85,611	10.39 USD	$889.5K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 21, 2022	Sell	-399,923	10.42 USD	$4.2M		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 12, 2020	OtherD (derivative)	-8,753,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 12, 2020	OtherD (derivative)	-3,644,624	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 12, 2020	Buy	200,000	15.00 USD	$3M	conv 52ClusterFirst in 12mo	SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 12, 2020	Other	3,473,374	—	n/a (No price was disclosed in the filing)		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 12, 2020	OtherD (derivative)	-12,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akero Therapeutics, Inc.Listing unverified	Jun 25, 2019	Buy	250,000	16.00 USD	$4M	conv 61ClusterFirst in 12mo	SEC
Akero Therapeutics, Inc.Listing unverified	Jun 25, 2019	OtherD (derivative)	-722,737	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akero Therapeutics, Inc.Listing unverified	Jun 25, 2019	Other	3,469,759	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Jun 25, 2019	Other	235,099	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Jun 25, 2019	OtherD (derivative)	-10,666,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Checkmate Pharmaceuticals, Inc.Listing unverified	May 4, 2022	Sell	-153,700	10.38 USD	$1.6M		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 4, 2022	Sell	-37,500	10.37 USD	$388.9K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	May 4, 2022	Sell	-79,475	10.37 USD	$824.2K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 21, 2022	Sell	-62,200	10.38 USD	$645.6K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 21, 2022	Sell	-85,611	10.39 USD	$889.5K		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Apr 21, 2022	Sell	-399,923	10.42 USD	$4.2M		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 12, 2020	OtherD (derivative)	-8,753,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 12, 2020	OtherD (derivative)	-3,644,624	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 12, 2020	Buy	200,000	15.00 USD	$3M	conv 52ClusterFirst in 12mo	SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 12, 2020	Other	3,473,374	—	n/a (No price was disclosed in the filing)		SEC
Checkmate Pharmaceuticals, Inc.Listing unverified	Aug 12, 2020	OtherD (derivative)	-12,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akero Therapeutics, Inc.Listing unverified	Jun 25, 2019	Buy	250,000	16.00 USD	$4M	conv 61ClusterFirst in 12mo	SEC
Akero Therapeutics, Inc.Listing unverified	Jun 25, 2019	OtherD (derivative)	-722,737	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Akero Therapeutics, Inc.Listing unverified	Jun 25, 2019	Other	3,469,759	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Jun 25, 2019	Other	235,099	—	n/a (No price was disclosed in the filing)		SEC
Akero Therapeutics, Inc.Listing unverified	Jun 25, 2019	OtherD (derivative)	-10,666,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC